Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cambrex Corp (CBM)

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,023,102
  • Shares Outstanding, K 33,724
  • Annual Sales, $ 532,090 K
  • Annual Income, $ 92,420 K
  • 60-Month Beta 2.13
  • Price/Sales 3.80
  • Price/Cash Flow 15.36
  • Price/Book 2.99
Trade CBM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.60
  • Most Recent Earnings 0.31 on 05/02/19
  • Next Earnings Date 11/14/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 14.000 on 05/04/07
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +2,497,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
59.72 +0.45%
on 11/04/19
59.99 unch
on 12/03/19
+0.19 (+0.32%)
since 11/01/19
3-Month
59.38 +1.03%
on 10/02/19
60.14 -0.25%
on 09/06/19
+0.43 (+0.72%)
since 09/03/19
52-Week
33.80 +77.49%
on 02/14/19
60.29 -0.50%
on 08/14/19
+10.73 (+21.78%)
since 12/03/18

Most Recent Stories

More News
Cambrex Introduces New Kilogram-Scale GMP Manufacturing Capabilities at Tallinn, Estonia Facility

, /PRNewswire/ -- Cambrex today announced the completion of an investment project at its facility in to upgrade its kilogram-scale laboratory to undertake the manufacture of pharmaceutical intermediates...

CBM : 59.99 (unch)
Worldwide Small Molecule API Industry to 2027 - Featuring Aurobindo Pharma, Cambrex and Catalent Among Others

The "Global Small Molecule API Market 2020-2027 by Source (Synthetic, Semi-synthetic, Natural), Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma,...

CBM : 59.99 (unch)
Cambrex Expands Analytical Services Capabilities at Longmont, Colorado, Facility

, /PRNewswire/ -- Cambrex today announced an expansion of cGMP analytical testing capabilities at its site in . Existing space at the site has been repurposed with cutting edge technologies and doubles...

CBM : 59.99 (unch)
Global Active Pharmaceutical Ingredients Markets Report 2020 with Profiles of Actavis, BASF, Cambrex, GlaxoSmithKline and Sun Pharmaceutical Industries

The "Active Pharmaceutical Ingredients: Global Markets" report has been added to ResearchAndMarkets.com's offering.

CBM : 59.99 (unch)
GSK : 40.66 (+0.22%)
Tobacco Alternative Gums Market 2020-2024 - Featuring Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Among Others to Contribute for the Market Growth

The tobacco alternative gums market is poised to grow by $ 660.60 mn during 2020-2024 progressing at a CAGR of almost 6% during the forecast period.

CBM : 59.99 (unch)
Global Nicotine Gum Market Trajectory & Analytics Report 2020-2027 Featuring Cambrex, Fertin Pharma, GlaxoSmithKline, Johnson & Johnson, Perrigo, Pfizer, Reynolds American - ResearchAndMarkets.com

The "Nicotine Gum - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

CBM : 59.99 (unch)
PRGO : 47.86 (+0.72%)
Cambrex to Invest $50 Million to Expand Multipurpose Large-Scale Manufacturing Capabilities in the U.S.

, /PRNewswire/ -- Cambrex today announced that it is expanding its mid-scale and large-scale API manufacturing capacity in . The $50+ million investment is designed to meet the continually growing demand...

CBM : 59.99 (unch)
Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh

, /PRNewswire/ -- Cambrex, announced today the completion of an expansion of its solid form screening and crystallization process development facility in . This major expansion project has seen the facility's...

CBM : 59.99 (unch)
ProAmpac Names Rita Cox President of Flexibles Products Division

ProAmpac, a leading global flexible packaging company, today announced that Rita Cox has been named President of the company's Flexibles Products division. Ms. Cox was previously President of the company's...

CBM : 59.99 (unch)
Cambrex Names Thomas Loewald as Chief Executive Officer

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Tom Loewald has been named Chief Executive...

CBM : 59.99 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 60.00
1st Resistance Point 59.99
Last Price 59.99
1st Support Level 59.98
2nd Support Level 59.98
3rd Support Level N/A

See More

52-Week High 60.29
Last Price 59.99
Fibonacci 61.8% 50.17
Fibonacci 50% 47.04
Fibonacci 38.2% 43.92
52-Week Low 33.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar